Skip to main content

Table 1 Inclusion and exclusion criteria

From: The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study

Inclusion criteria

Planned primary surgery for suspected or verified primary breast malignancy

Age ≥ 18 years

Signed informed consent

Exclusion criteria

Planned neoadjuvant therapy

On-going pregnancy

Iodinated contrast agent allergy

Renal disease or abnormal S-creatinin (normal range 45–90 μmol/l)

Untreated thyrotoxicosis (including multinodular goitre) (upon suspicion check P-thyrotropin level, exclusion if < 0.4 mIE/l)

Severe heart failure

Myastenia gravis

Breast implant

Local recurrence as index lesion

Inability to understand oral or written information about the study